Bliss GVS Pharma Ltd Financial Statements

Bliss GVS Pharma Ltd Balance Sheet

  • Tabular Data
  • Graph
  • Consolidated
  • Standalone
Y/e 31 Mar ( In .Cr) Mar-2022 Mar-2021 Mar-2020 Mar-2019
Equity capital 10.40 10.30 10.30 10.30
Preference capital -- -- -- --
Reserves 808 798 725 636
Net worth 819 808 736 646
Minority interest
Debt 109 122 126 102
Deferred tax liabilities (net) 14.50 11.80 7.13 4.54
Total liabilities 970 962 884 766
Fixed assets 304 237 242 192
Intangible assets
Investments 2.39 0.01 0.02 0.02
Deferred tax asset (net) 13.20 3.59 3.57 0.96
Net working capital 474 577 535 466
Inventories 124 98.90 76.90 77.40
Inventory Days 60.50 62.60 40.70 --
Sundry debtors 393 464 548 461
Debtor days 192 293 290 --
Other current assets 109 133 60.20 67.70
Sundry creditors (118) (80) (94) (93)
Creditor days 57.50 50.70 49.90 --
Other current liabilities (34) (39) (56) (47)
Cash 178 145 103 107
Total assets 970 962 884 766

Invest wise with Expert advice

Open Demat Account

Invest wise with Expert advice

By continuing, I accept the Terms & Conditions and agree to receive updates on Whatsapp